Physician

Anthony W Clay, D.O.

According to 2025 Medicare claims, Anthony Clay, D.O. (NPI: 1649202573) practices cardiology in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from New Castle, DE. This provider's primary affiliated billing organization is CARDIOLOGY PHYSICIANS, LLC (NPI: 1952338212; TIN: 510363108) and primary practice location at 19713-2150. Clay is affiliated with the eBrightHealth ACO (ACO ID: A3053), participating under the MSSP model.

Clay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,008 traditional Medicare patients, billed 10,617 HCPCS/CPT codes, and received $1,709,302 in Medicare payments. The top billing code was 78434 (Nuclear medicine study of heart muscle blood flow by pet). Part D data shows 6,574 prescription claims across 1,007 beneficiaries totaling $1,502,590 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 24 claims. Open Payments data shows 21 records totaling $727,356. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $647,928 to $1,709,302. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $430,377 to $1,502,590. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,092	9,595	$647,928
2016	3,464	10,028	$727,167
2017	3,509	10,473	$800,854
2018	3,798	10,761	$926,664
2019	3,916	11,438	$1,005,342
2020	3,884	10,540	$1,268,704
2021	3,773	11,548	$1,378,378
2022	3,469	9,243	$1,017,445
2023	3,254	9,618	$1,250,242
2024	3,008	10,617	$1,709,302

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	531	3,368	$430,377
2016	605	3,665	$491,130
2017	721	4,196	$643,061
2018	762	4,696	$757,131
2019	793	5,193	$949,445
2020	899	5,894	$1,196,681
2021	952	5,987	$1,300,711
2022	985	6,149	$1,540,224
2023	980	6,090	$1,591,096
2024	1,007	6,574	$1,502,590

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	24	$1,013
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78434	Nuclear medicine study of heart muscle blood flow by pet	408	408	$537
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,241	2,024	$90
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	519	520	$55
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,243	1,614	$10
J2785	Injection, regadenoson, 0.1 mg	458	1,832	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	425	28,553	$540,559
Xarelto	Rivaroxaban	378	26,875	$489,296
Entresto	Sacubitril/Valsartan	93	6,810	$134,826
Repatha Sureclick	Evolocumab	83	4,314	$78,798
Farxiga	Dapagliflozin Propanediol	34	2,430	$43,361

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$2,161	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	14	$725,195	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anthony W. Clay, D.O.?

Tedicare shows public-source Medicare data for Anthony W. Clay, D.O. (NPI 1649202573), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony W. Clay, D.O. have ACO affiliation data?

Anthony W. Clay, D.O. is shown with ACO affiliation data for eBrightHealth ACO (MSSP, ACO ID A3053).

What billing organization is linked to Anthony W. Clay, D.O.?

Anthony W. Clay, D.O. is linked to CARDIOLOGY PHYSICIANS, LLC (billing NPI 1952338212) in the available physician profile data.

Does Anthony W. Clay, D.O. have Open Payments data?

Anthony W. Clay, D.O. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.